Why are imaging biomarkers important?
Imaging tools can help detect and treat diseases earlier, and potentially reduce the financial burden pressuring healthcare. A broad group of stakeholders is emerging across healthcare, BioPharma, governmental and software vendor industries – all need insights from these technologies. Imaging biomarkers augment traditional and genetic information to help researchers and medical practitioners characterize tumors, assess target expression and treatment effectiveness, as well as to monitor target inhibition. Biomarkers, however, require a substantial amount of supporting data to evolve from characterizing target populations to become a widely-accepted surrogate clinical endpoint. Depicts the progressive utility associated with more supportive data. Many imaging biomarkers fail to reach surrogate status, because they do not address the target treatment effects or relevant pathophysiology of the disease. More robust imaging can provide new insights to improve efficiency in medical practice
